Clinical Trial Update: Study of Convernsion Therapy Using S1/Paclitaxel Chemotherapy Plus Apatinib in Unresectable Gastric Cancer [Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 2 study evaluating conversion therapy with S1/paclitaxel chemotherapy plus apatinib for unresectable gastric cancer…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• Apatinib (apatinib)
• PACLITAXEL (PACLITAXEL)
• S-1 (tegafur/gimeracil/oteracil)

Snippet

Sponsor: The First Affiliated Hospital of Zhejiang Chinese Medical University | Conditions: Gastric Cancer | Phase 2 | Status: UNKNOWN